comparemela.com

Latest Breaking News On - Sondras newman - Page 1 : comparemela.com

Repligen Corporation to Present at Upcoming June Investor Conferences

WALTHAM, Mass., May 22, 2024 Repligen Corporation , a life sciences company focused on bioprocessing technology leadership, today announced that it will be presenting at the following June.

United statesNew yorkWilliam blairOlivier loeillotSondras newmanGlobenewswire incRepligen corporationStock conferenceChief executive officerGlobal healthcare conferenceChief commercial officerChief financial officerInvestor relationsFluid managementProcess analytics

Repligen Corp (RGEN) Reports Decline in 2023 Revenue and Net Income

Challenging Year Leads to Lower Financial Metrics Despite Strong Order Book

Sondras newmanRepligen corpFinancial metricsGlobal headInvestor relationsGross marginTotal revenueFinancial guidanceFinancial metrics

Repligen Reports Fourth Quarter and Full Year 2023 Financial Results

Reports fourth quarter revenue of $156 million and full year revenue of $639 millionContinued strength in orders with fourth quarter book-to-bill ratio of 1.03

United statesSondras newmanExchange commission theSecurities exchangeCurrency exchangeRevenue growthDrug administrationEuropean medicines evaluation agencyRepligen corporationChief executive officerFluid managementTangential flow filtrationPer shareInvestor relationsProcess analyticsPrivate securities litigation reform act

Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1 00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription Agreements

WALTHAM, Mass., Dec. 07, 2023 Repligen Corporation today announced that on December 6, 2023, it entered into privately negotiated exchange and/or subscription agreements with certain holders of.

United statesSondras newmanEuropean medicines evaluation agencyExchange commissionDrug administrationWood capital advisorsExchange transactionsSecurities exchangeGlobenewswire incRepligen corporationConvertible senior notesNew notesSubscription transactionsChief financial officerCurrent reportPerella weinberg partners

Repligen Announces Publication of the Company s 2022 Sustainability Report

WALTHAM, Mass., Nov. 14, 2023 (GLOBE NEWSWIRE) Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technolog.

United statesDianne heilerSondras newmanTony huntGlobal reporting initiativeUnited nations sustainable development goals un sdgsExchange commissionRepligen corporationTask force on climateReporting indexesSustainability accounting standards boardUnited nations sustainable development goalsTask forceClimate related disclosuresChief executive officerSenior director

vimarsana © 2020. All Rights Reserved.